Anaplastic Lymphoma Kinase (ALK)-Induced Malignancies: Novel Mechanisms of Cell Transformation and Potential Therapeutic Approaches
To access this article, please choose from the options below
Supported in part by the grants from the National Institutes of Health and Cephalon, Inc.
STATEMENT OF CONFLICT OF INTEREST: Dr Wasik is a member of Cephalon's Scientific Advisory Board and has received a short-term research grant from Cephalon. The other authors have nothing to disclose.
PII: S0093-7754(09)00035-9
doi:10.1053/j.seminoncol.2009.02.007
© 2009 Elsevier Inc. All rights reserved.
